Clinical trial

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

NCT02424344

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-04-27

PhasePHASE4

Study timeline

Study start (actual)2015-04-27Date precision: day

Registry last updated2018-10-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

Aclidinium/FormoterolDRUG

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Menarini Groupcollaborator

Mapped research locations

BerlinGermany5 HamburgGermany2 MadridSpain1 BudapestHungary1 HamiltonOntario, Canada1 MünchenGermany1 HanoverGermany1 FrankfurtGermany1 KingstonOntario, Canada1 AlicanteSpain1 SaskatoonSaskatchewan, Canada1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02424344 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.